Calidi Biotherapeutics, Inc.
CLDI- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $89.3K in total; no superinvestor holds it.
Other share classesCLDWW
13F holders, Q4 2023
Institutional positions in Calidi Biotherapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +12 vs. Q3 2023
- Shares held
- 1.90M
- +828.7K (+77.2%) vs. Q3 2023
- Total value
- $2.83M
- −$714.4K (−20.2%) vs. Q3 2023
- New holders
- 15
- 2 more added
- Sold out
- 3
- 1 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLDI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $89.3K |
| Q1 2026 | 28 | $478.8K |
| Q4 2025 | 27 | $524.7K |
| Q3 2025 | 22 | $353.6K |
| Q2 2025 | 35 | $656.8K |
| Q1 2025 | 36 | $3.09M |
| Q4 2024 | 33 | $1.27M |
| Q3 2024 | 20 | $363.4K |
| Q2 2024 | 32 | $523.2K |
| Q1 2024 | 31 | $1.56M |
| Q4 2023 | 25 | $3.29M |
| Q3 2023 | 13 | $3.54M |
| Q2 2023 | 25 | $40.6M |
| Q1 2023 | 27 | $45.8M |
| Q4 2022 | 25 | $39.6M |
| Q3 2022 | 21 | $36.1M |
| Q2 2022 | 42 | $214.8M |
| Q1 2022 | 40 | $202.4M |
| Q4 2021 | 27 | $184.1M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Calidi Biotherapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cable Car Capital LLC | 538,860 | $813.7K | 0.85% | +538,860 | New |
| Meteora Capital, LLC | 288,826 | $436.1K | 0.07% | −144,898−33.4% | Reduced |
| Spectrum Asset Management, Inc. (NB/CA) | 166,494 | $251.4K | 0.11% | +83,247+100.0% | Added |
| Finepoint Capital LP | 125,000 | $188.8K | 0.07% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 125,000 | $162.1K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 102,317 | $154.5K | 0.00% | +102,317 | New |
| Geode Capital Management, LLC | 102,238 | $154.4K | 0.00% | +102,238 | New |
| Driehaus Capital Management LLC | 94,697 | $143.0K | 0.00% | 00.0% | Unchanged |
| Governors Lane LP | 94,697 | $143.0K | 0.04% | +94,697 | New |
| Red Wave Investments LLC | 56,549 | $85.4K | 0.03% | 00.0% | Unchanged |
| Magnetar Financial LLC | 63,132 | $75.6K | 0.00% | +63,132 | New |
| Pegasus Partners Ltd. | 37,812 | $57.1K | 0.01% | +37,812 | New |
| Morgan Stanley | 19,187 | $29.0K | 0.00% | +19,187 | New |
| Renaissance Technologies LLC | 17,079 | $26.0K | 0.00% | +17,079 | New |
| HRT Financial LP | 16,559 | $25.0K | 0.00% | +6,248+60.6% | Added |
| Axxcess Wealth Management, LLC | 13,190 | $19.9K | 0.00% | +13,190 | New |
| Vanguard Group Inc | 12,448 | $18.8K | 0.00% | +12,448 | New |
| Pure Financial Advisors, Inc. | 11,892 | $18.0K | 0.00% | +11,892 | New |
| Delta Investment Management, LLC | 10,230 | $15.4K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 2,752 | $4.16K | 0.00% | +2,752 | New |
| BlackRock Inc. | 2,588 | $3.91K | 0.00% | +2,588 | New |
| Wells Fargo & Company | 138 | $208 | 0.00% | +138 | New |
| The PNC Financial Services Group, Inc. | 100 | $151 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 10 | $15 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1 | $2 | 0.00% | +1 | New |
| Highbridge Capital Management LLC | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| Kayne Anderson Rudnick Investment Management LLC | 0 | $0 | 0.00% | −9,174−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −100−100.0% | Sold out |